TELEO Capital acquires Modersys from Applied Materials
Operating as an independent company, Modersys will focus on accelerating AI-driven manufacturing intelligence for biopharmaceutical, nutritional, and life sciences companies globally.
Takeaways
- Modersys is a pharmaceutical manufacturing intelligence platform.
- TELEO Capital Management is acquiring Modersys.
- The business serves biopharmaceutical and life sciences manufacturing.
TELEO Capital Management has acquired Modersys, a pharmaceutical manufacturing intelligence software provider, from Applied Materials, spinning the unit out as an independent company.
The platform combines real-time analytics, AI/ML process intelligence, and advanced process control to help biopharmaceutical, nutritional, and life sciences manufacturers improve yield, reduce variability, and maintain regulatory compliance.
With over 30 years of expertise, Modersys has been deployed across the U.S., Europe, and Asia Pacific.
"Modersys represents exactly the kind of mission-critical, deeply differentiated software platform that we were built to acquire," stated TELEO Capital.
The business was rebranded from SmartFactory Rx as part of the transaction.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.